• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 0.05% Nasdaq Up 0.17%

    Biogen Inc. (BIIB)

    -NasdaqGS
    285.13 Up 0.38(0.13%) Feb 24, 4:00PM EST
    |After Hours : 285.13 0.00 (0.00%) Feb 24, 6:29PM EST
    Prev Close:284.75
    Open:285.01
    Bid:266.06 x 200
    Ask:285.15 x 100
    1y Target Est:322.07
    Beta:0.499955
    Earnings Date:Apr 19 - Apr 24 (Est.)
    Day's Range:266.00 - 285.81
    52wk Range:223.02 - 333.65
    Volume:1,768,544
    Avg Vol (3m):1,790,240
    Market Cap:61.57B
    P/E (ttm):16.84
    EPS (ttm):16.93
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Comparison

    Symbol% ChgMkt Cap
    BIIBUp 0.13%61.57B
    1 0.00%N/A
    PFEUp 0.59%207.90B
    ABTUp 0.62%78.85B

    Key Statistics

    Forward P/E (1 yr):12.71
    P/S (ttm):5.37
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-17) :20.99
    Quarterly EPS Est (Mar-17) :5.00
    Mean Recommendation*:2.0
    PEG Ratio (5 yr expected):2.16

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Biogen Inc., a biopharmaceutical company, discovers, develops, manufactures, and delivers therapies for the treatment of neurological and autoimmune diseases worldwide. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback